PTI - ペイン・セラピュ―ティックス (Proteostasis Therapeutics Inc.)

PTIのニュース

   PROTEOSTASIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Proteostasis Therapeutics, Inc. - PTI  2020/08/26 22:24:00 Business Wire
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Proteostasis Therapeutics, Inc. (NasdaqGM: PTI) with Yumanity Therapeutics, Inc. in a stock-for-stock transaction. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you believe that this transaction undervalues the Co
   Navigator e Portucel Moçambique rejeitam dívidas e avançam judicialmente contra alegados credores  2020/08/11 08:18:39 Jornal de Negócios
A The Navigator Company (ex-Portucel) e a Portucel Moçambique avançaram com ações judiciais em Portugal e Moçambique contra empresas fornecedoras de serviços florestais que alegaram ser suas credoras e reclamaram prejuízos no país africano, segundo documentos consultados hoje pela Lusa.
   Proteostasis (PTI) to Report Q4 Earnings: What's in Store?  2020/02/26 14:56:00 Zacks Investment Research
We expect Proteostasis Therapeutics (PTI) to provide updates on its pipeline when its releases fourth-quarter 2019 results.
   Proteostasis Therapeutics Announces New Publication on the Mechanism of Action of a Novel Class of CFTR Modulators Called Amplifiers in the Journal of Cystic Fibrosis  2020/02/25 12:00:00 PR Newswire
BOSTON, Feb. 25, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced the publication of nonclinical data on the…
   Is Proteostasis Therapeutics (PTI) Stock Outpacing Its Medical Peers This Year?  2020/01/06 16:30:11 Zacks Investment Research
Is (PTI) Outperforming Other Medical Stocks This Year?
   PROTEOSTASIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Proteostasis Therapeutics, Inc. - PTI  2020/08/26 22:24:00 Business Wire
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Proteostasis Therapeutics, Inc. (NasdaqGM: PTI) with Yumanity Therapeutics, Inc. in a stock-for-stock transaction. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you believe that this transaction undervalues the Co
   Navigator e Portucel Moçambique rejeitam dívidas e avançam judicialmente contra alegados credores  2020/08/11 08:18:39 Jornal de Negócios
A The Navigator Company (ex-Portucel) e a Portucel Moçambique avançaram com ações judiciais em Portugal e Moçambique contra empresas fornecedoras de serviços florestais que alegaram ser suas credoras e reclamaram prejuízos no país africano, segundo documentos consultados hoje pela Lusa.
   Proteostasis (PTI) to Report Q4 Earnings: What's in Store?  2020/02/26 14:56:00 Zacks Investment Research
We expect Proteostasis Therapeutics (PTI) to provide updates on its pipeline when its releases fourth-quarter 2019 results.
   Proteostasis Therapeutics Announces New Publication on the Mechanism of Action of a Novel Class of CFTR Modulators Called Amplifiers in the Journal of Cystic Fibrosis  2020/02/25 12:00:00 PR Newswire
BOSTON, Feb. 25, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced the publication of nonclinical data on the…
   Is Proteostasis Therapeutics (PTI) Stock Outpacing Its Medical Peers This Year?  2020/01/06 16:30:11 Zacks Investment Research
Is (PTI) Outperforming Other Medical Stocks This Year?
   PROTEOSTASIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Proteostasis Therapeutics, Inc. - PTI  2020/08/26 22:24:00 Business Wire
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Proteostasis Therapeutics, Inc. (NasdaqGM: PTI) with Yumanity Therapeutics, Inc. in a stock-for-stock transaction. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you believe that this transaction undervalues the Co
   Navigator e Portucel Moçambique rejeitam dívidas e avançam judicialmente contra alegados credores  2020/08/11 08:18:39 Jornal de Negócios
A The Navigator Company (ex-Portucel) e a Portucel Moçambique avançaram com ações judiciais em Portugal e Moçambique contra empresas fornecedoras de serviços florestais que alegaram ser suas credoras e reclamaram prejuízos no país africano, segundo documentos consultados hoje pela Lusa.
   Proteostasis (PTI) to Report Q4 Earnings: What's in Store?  2020/02/26 14:56:00 Zacks Investment Research
We expect Proteostasis Therapeutics (PTI) to provide updates on its pipeline when its releases fourth-quarter 2019 results.
   Proteostasis Therapeutics Announces New Publication on the Mechanism of Action of a Novel Class of CFTR Modulators Called Amplifiers in the Journal of Cystic Fibrosis  2020/02/25 12:00:00 PR Newswire
BOSTON, Feb. 25, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced the publication of nonclinical data on the…
   Is Proteostasis Therapeutics (PTI) Stock Outpacing Its Medical Peers This Year?  2020/01/06 16:30:11 Zacks Investment Research
Is (PTI) Outperforming Other Medical Stocks This Year?

calendar